Literature DB >> 25624301

Time to be cautious about prescribing sulfonylureas?

Mick Dwyer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25624301      PMCID： PMC4325462          DOI： 10.3399/bjgp15X683617

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  15 in total

1.  Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality.

Authors:  C Ll Morgan; J Mukherjee; S Jenkins-Jones; S E Holden; C J Currie
Journal:  Diabetes Obes Metab       Date:  2014-05-22       Impact factor: 6.577

2.  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.

Authors:  M G Goldner; G L Knatterud; T E Prout
Journal:  JAMA       Date:  1971-11       Impact factor: 56.272

3.  Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

Authors:  Jeffrey A Johnson; Sumit R Majumdar; Scot H Simpson; Ellen L Toth
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

4.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

5.  Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.

Authors:  J M M Evans; S A Ogston; A Emslie-Smith; A D Morris
Journal:  Diabetologia       Date:  2006-03-09       Impact factor: 10.122

Review 6.  Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis.

Authors:  O J Phung; E Schwartzman; R W Allen; S S Engel; S N Rajpathak
Journal:  Diabet Med       Date:  2013-10       Impact factor: 4.359

Review 7.  Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.

Authors:  Bianca Hemmingsen; Søren S Lund; Christian Gluud; Allan Vaag; Thomas Almdal; Christina Hemmingsen; Jørn Wetterslev
Journal:  BMJ       Date:  2011-11-24

8.  Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors:  Ralph A Defronzo
Journal:  Diabetes       Date:  2009-04       Impact factor: 9.461

9.  Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

Authors:  Ioanna Tzoulaki; Mariam Molokhia; Vasa Curcin; Mark P Little; Christopher J Millett; Anthea Ng; Robert I Hughes; Kamlesh Khunti; Martin R Wilkins; Azeem Majeed; Paul Elliott
Journal:  BMJ       Date:  2009-12-03

10.  Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies.

Authors:  Ajay D Rao; Nitesh Kuhadiya; Kristi Reynolds; Vivian A Fonseca
Journal:  Diabetes Care       Date:  2008-05-05       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.